Market Tracker

03/28 7:51am ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.25
Delayed Data
As of Mar 27
 +0.05 / +1.56%
Today’s Change
2.35
Today|||52-Week Range
5.48
+32.65%
Year-to-Date

Today’s Trading

Previous close3.20
Today’s open3.25
Day’s range3.20 - 3.30
Volume117,823
Average volume (3 months)302,077
Market cap$178.8M
Dividend yield--
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratio--
Price/Sales87.21
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
MDGLMadrigal Pharmaceuti...+0.28+1.84%
IMDZImmune Design Corp+0.45+6.98%
RDHLRedhill Biopharma Lt...-0.24-2.29%
MNKDMannKind Corp-0.07-3.70%
Data as of 03/27/2017

Financials

Last reporting dateMarch 22, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts